Oncology & Staging

Lung Cancer Screening & Nodule Pathways

Summarizes eligibility requirements, program infrastructure, nodule follow-up algorithms, reimbursement coding, and approach to positive screens and quality metrics.

Screening guidelines • Nodule management • Program metricsReading time · 26mWord count · 3,935

Track your progress—Lung Cancer Screening & Nodule Pathways will stay highlighted in the catalog.

Exam mapping & scope

Mapped to: AABIP/CAQ IP domains on oncologic diagnostics and programmatic screening. Key Topics: Eligibility, shared decision-making, CTLS technical standards, Lung-RADS v2022, nodule management and escalation (PET/CT, biopsy, bronchoscopy, surgery), benefits/harms (mortality, false positives, complications, radiation), special populations (COPD/ILD, cancer survivors), and evolving tools (risk models, biomarkers).

Focus this round

  • Eligibility pathways
  • Algorithm memorization
  • Quality requirements